RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

NCT00263263 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Stable Angina
Unstable Angina
Coronary Artery Disease
Saphenous Vein Graft Disease

Interventions

DEVICE: sirolimus-eluting stent
DEVICE: bare metal stent

Sponsor

Antwerp Cardiovascular Institute Middelheim